Dr Allen Jeremias (St. Francis Hospital, Roslyn, NY, US) discusses the DEFINE PCT Trial - Blinded assessment of residual ischaemia after successful angiographic PCI.
Filmed on site at ACC 2019 by Radcliffe Cardiology
1. What is DEFINE PCI and why is it needed?
2. What is the study design and endpoints?
3. What were your findings?
4. How should this trial impact practice ?
5. How will DEFINE PCI influence future research in post-PCI coronary physiology ?
Videography: Josh Birch
Interviewer: Liam O’Neill